Skip to main content

17 November 2025

Last updated: Sunday 16 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

TiGenix cell therapy makes regulatory history

Wednesday 5 August 2009

Interviewee/Contributor

Gil Beyen

Organisation

TiGenix NV

Organisations

Janssen Oncology
Eli Lilly and Company
Evernow Publishing Ltd
CEVEC Pharmaceuticals GmbH
Institute for Clinical and Economic Review
IP Group
Novo Nordisk Biotech Fund
DeepVerge Plc
Odlander, Fredrikson and Co AB
Cell Medica

Interviewees and Contributers

Mick Cooper
Hugh Davies
Tim Knotnerus
Lukas Heukamp
Jürg Eckhardt
Dr Konrad Glund
Montserrat Vendrell
Sander Slootweg
Catherine Taylor
Paula Salmikangas and Björn Carlsson and Steffen Thirstrup

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form